FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016044148> ?p ?o ?g. }

• W2016044148 endingPage "1609" @default.
• W2016044148 startingPage "1605" @default.
• W2016044148 abstract "Inflammation contributes to the pathogenesis of cardiovascular disease. Tumour necrosis factor (TNF)-alpha, in particular, is a key mediator of inflammation and vascular dysfunction and progression of atherosclerotic disease. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, not only improves insulin sensitivity, but may also have anti-inflammatory effects. The aims of this study were to investigate the acute effects of local intra-arterial infusion with low-dose TNF-alpha on resistance vessel endothelial function in type 2 diabetes and to determine whether short-term pioglitazone treatment protects against vascular dysfunction induced by this inflammatory stimulus.A randomized, parallel, placebo-controlled, double blind trial with 30 mg pioglitazone once daily for 4 weeks was performed in 16 male patients with recently diagnosed type 2 diabetes. Forearm plethysmography (FBF) was used to evaluate the effect on resistance vessel responses of intra-arterial administration of serotonin (NO-dependent vasodilation) and nitroprusside (endothelium-independent vasodilation) followed by another FBF-measurement during the second hour of intra-arterial infusion with TNF-alpha (10 ng/100 mL forearm volume/min for 2 h). Endothelial-dependent FBF of type 2 diabetic patients was significantly impaired (25.4%) by intra-arterial TNF-alpha infusion (P = 0.01), whereas nitroprusside-induced vasodilation did not change. Treatment with pioglitazone for 4 weeks completely blocked TNF-alpha-induced impairment of endothelial-dependent FBF compared with placebo. No significant changes in plasma concentrations of TNF-alpha, interleukin-6, soluble TNF-alpha-receptors, or CD40L were observed.Pioglitazone treatment can convey direct protection against cytokine (TNF-alpha)-induced endothelial dysfunction in humans with an increased cardiovascular risk due to type 2 diabetes." @default.
• W2016044148 created "2016-06-24" @default.
• W2016044148 creator A5014436977 @default.
• W2016044148 creator A5020130906 @default.
• W2016044148 creator A5038662049 @default.
• W2016044148 creator A5073320977 @default.
• W2016044148 creator A5075309331 @default.
• W2016044148 date "2006-06-08" @default.
• W2016044148 modified "2023-10-17" @default.
• W2016044148 title "TNF-α induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-γ agonist pioglitazone" @default.
• W2016044148 cites W1484535674 @default.
• W2016044148 cites W1580962701 @default.
• W2016044148 cites W1964527977 @default.
• W2016044148 cites W1969348726 @default.
• W2016044148 cites W1977543113 @default.
• W2016044148 cites W1990529844 @default.
• W2016044148 cites W1994269792 @default.
• W2016044148 cites W1997030483 @default.
• W2016044148 cites W1997443963 @default.
• W2016044148 cites W2008288517 @default.
• W2016044148 cites W2011450430 @default.
• W2016044148 cites W2015219110 @default.
• W2016044148 cites W2021025717 @default.
• W2016044148 cites W2047852384 @default.
• W2016044148 cites W2050092688 @default.
• W2016044148 cites W2051727048 @default.
• W2016044148 cites W2054727930 @default.
• W2016044148 cites W2063281374 @default.
• W2016044148 cites W2067504868 @default.
• W2016044148 cites W2080588890 @default.
• W2016044148 cites W2086033018 @default.
• W2016044148 cites W2102469433 @default.
• W2016044148 cites W2110641080 @default.
• W2016044148 cites W2114633474 @default.
• W2016044148 cites W2116059341 @default.
• W2016044148 cites W2128899850 @default.
• W2016044148 cites W2130087704 @default.
• W2016044148 cites W2133055307 @default.
• W2016044148 cites W2137788779 @default.
• W2016044148 cites W2145570729 @default.
• W2016044148 cites W2171533490 @default.
• W2016044148 cites W2316167515 @default.
• W2016044148 cites W4240449862 @default.
• W2016044148 doi "https://doi.org/10.1093/eurheartj/ehl079" @default.
• W2016044148 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16762982" @default.
• W2016044148 hasPublicationYear "2006" @default.
• W2016044148 type Work @default.
• W2016044148 sameAs 2016044148 @default.
• W2016044148 citedByCount "74" @default.
• W2016044148 countsByYear W20160441482012 @default.
• W2016044148 countsByYear W20160441482013 @default.
• W2016044148 countsByYear W20160441482014 @default.
• W2016044148 countsByYear W20160441482015 @default.
• W2016044148 countsByYear W20160441482016 @default.
• W2016044148 countsByYear W20160441482017 @default.
• W2016044148 countsByYear W20160441482018 @default.
• W2016044148 countsByYear W20160441482019 @default.
• W2016044148 countsByYear W20160441482020 @default.
• W2016044148 countsByYear W20160441482021 @default.
• W2016044148 countsByYear W20160441482023 @default.
• W2016044148 crossrefType "journal-article" @default.
• W2016044148 hasAuthorship W2016044148A5014436977 @default.
• W2016044148 hasAuthorship W2016044148A5020130906 @default.
• W2016044148 hasAuthorship W2016044148A5038662049 @default.
• W2016044148 hasAuthorship W2016044148A5073320977 @default.
• W2016044148 hasAuthorship W2016044148A5075309331 @default.
• W2016044148 hasBestOaLocation W20160441481 @default.
• W2016044148 hasConcept C120770815 @default.
• W2016044148 hasConcept C126322002 @default.
• W2016044148 hasConcept C134018914 @default.
• W2016044148 hasConcept C2776992346 @default.
• W2016044148 hasConcept C2777180221 @default.
• W2016044148 hasConcept C2777391703 @default.
• W2016044148 hasConcept C2778384471 @default.
• W2016044148 hasConcept C2780972559 @default.
• W2016044148 hasConcept C555293320 @default.
• W2016044148 hasConcept C71924100 @default.
• W2016044148 hasConceptScore W2016044148C120770815 @default.
• W2016044148 hasConceptScore W2016044148C126322002 @default.
• W2016044148 hasConceptScore W2016044148C134018914 @default.
• W2016044148 hasConceptScore W2016044148C2776992346 @default.
• W2016044148 hasConceptScore W2016044148C2777180221 @default.
• W2016044148 hasConceptScore W2016044148C2777391703 @default.
• W2016044148 hasConceptScore W2016044148C2778384471 @default.
• W2016044148 hasConceptScore W2016044148C2780972559 @default.
• W2016044148 hasConceptScore W2016044148C555293320 @default.
• W2016044148 hasConceptScore W2016044148C71924100 @default.
• W2016044148 hasIssue "13" @default.
• W2016044148 hasLocation W20160441481 @default.
• W2016044148 hasLocation W20160441482 @default.
• W2016044148 hasOpenAccess W2016044148 @default.
• W2016044148 hasPrimaryLocation W20160441481 @default.
• W2016044148 hasRelatedWork W1982811953 @default.
• W2016044148 hasRelatedWork W1989708292 @default.
• W2016044148 hasRelatedWork W2003150205 @default.
• W2016044148 hasRelatedWork W2130813387 @default.
• W2016044148 hasRelatedWork W2139568581 @default.
• W2016044148 hasRelatedWork W2140626451 @default.

• next